glp-1 and eating disorder Receptor Agonists Research to Treat Overeating and Substance Use Disorders GLP-1 Agonist for Binge Eating

31 In a trial evaluating semaglutide for weight loss, the incidence of acute pancreatitis was still low (3 of 1,306 participants) despite a higher dose and more significant weight loss, but none of the 655 individuals in the placebo group developed pancreatitis

Endothelial cell mechanics and dynamics in angiogenesis

Changes in quality of life and symptoms in a large cohort of patients with gastroparesis followed prospectively for 48 weeks

However, when it comes to B12, the form in which it is delivered can make all the difference

Consistent terminology for research-only scope language Umbrella Labs standardized how research-only scope statements appear across records so that the same non-clinical language is used consistently